What is he best known for?
The fields of study he is best known for:
Takaji Wakita spends much of his time researching Virology, Virus, Hepatitis C virus, Viral replication and Molecular biology.
Particularly relevant to Interferon is his body of work in Virology.
His Virus research is multidisciplinary, incorporating perspectives in Antibody and Transfection.
His Hepatitis C virus study introduces a deeper knowledge of Immunology.
His Viral replication study combines topics in areas such as Peptide sequence, Biochemistry, Binding site and Expression vector.
His Molecular biology research includes themes of Gene knockdown, Complementary DNA, Cell biology, Regulation of gene expression and Viral protein.
His most cited work include:
- Production of infectious hepatitis C virus in tissue culture from a cloned viral genome (2514 citations)
- Robust hepatitis C virus infection in vitro (1594 citations)
- The lipid droplet is an important organelle for hepatitis C virus production. (1004 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Virology, Hepatitis C virus, Virus, Molecular biology and Cell culture.
His Virology study combines topics from a wide range of disciplines, such as RNA, Antibody and Genotype.
His Antibody research is multidisciplinary, incorporating elements of Antigen and Hepatitis E virus.
His Hepatitis C virus research incorporates elements of Interferon and Replicon.
His Virus study is associated with Immunology.
Takaji Wakita combines subjects such as Biochemistry, Nucleic acid and NS5B with his study of Molecular biology.
He most often published in these fields:
- Virology (71.89%)
- Hepatitis C virus (42.45%)
- Virus (29.25%)
What were the highlights of his more recent work (between 2017-2021)?
- Virology (71.89%)
- Hepatitis B virus (13.77%)
- Virus (29.25%)
In recent papers he was focusing on the following fields of study:
Virology, Hepatitis B virus, Virus, Hepatitis C virus and Cell culture are his primary areas of study.
He is interested in Viral replication, which is a branch of Virology.
In his study, RNA, Ceramide and Replicon is strongly linked to Cell biology, which falls under the umbrella field of Viral replication.
His studies in Hepatitis B virus integrate themes in fields like Receptor, Cancer research and Interferon.
His biological study spans a wide range of topics, including Phylogenetic tree and Adaptive mutation.
His Hepatitis C virus research is multidisciplinary, relying on both Hepatocellular carcinoma, Hepatitis D virus, Occludin and Gene.
Between 2017 and 2021, his most popular works were:
- Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19) (125 citations)
- Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies (77 citations)
- Initial Investigation of Transmission of COVID-19 Among Crew Members During Quarantine of a Cruise Ship - Yokohama, Japan, February 2020. (62 citations)
In his most recent research, the most cited papers focused on:
His primary scientific interests are in Virology, Hepatitis B virus, Virus, Severe acute respiratory syndrome coronavirus 2 and Coronavirus disease 2019.
Takaji Wakita has included themes like In vitro, Immune system and Hepatitis E virus in his Virology study.
The concepts of his Hepatitis B virus study are interwoven with issues in Receptor, Internalization and Cancer research.
His study in Antibody extends to Virus with its themes.
His Severe acute respiratory syndrome coronavirus 2 study integrates concerns from other disciplines, such as Asymptomatic and Outbreak, 2019-20 coronavirus outbreak.
Takaji Wakita works on Hepatitis C virus which deals in particular with Hcv vaccine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
